National Health Council Launches PXI to Involve Patients in Health AI Innovation
The National Health Council announced in a press release the launch of PXI: Patient Experience + Innovation Center, a national initiative aimed at ensuring patients and caregivers play a key role in shaping artificial intelligence and digital health technologies.
The PXI Center operates under a concierge model that connects innovators, researchers, nonprofits, and investors with patients and caregivers across the United States. This model allows collaborators to integrate patient experiences into the design, implementation, and evaluation of health technologies.
PXI includes a Stakeholder Collaborative, a tiered partnership structure that supports diverse participants, and Pathways to Partnership, which allows smaller organizations to engage regardless of budget. The initiative also offers educational resources, collaborative projects, and leadership networks to advance patient-informed innovation.
The launch follows the Council’s partnership with Sphere, the company behind the AI platform OrgBrain, to promote patient-centered integration of AI across health organizations.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Policy Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Regulation
Nov 13 Senate advances permitting bill that would speed energy projects for data centers Nov 12 Congress leaders back tighter AI chip export curbs after Nvidia scandal Nov 12 South Australia backs gas power for AI data centres despite renewables strategy Nov 12 Ontario Securities Commission finds most registered firms early in AI adoption Nov 12 France to open international defence AI centre in Rennes in July 2027More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
BRAINIAC hub receives £20 million for AI dementia clinics
ACL Digital Launches AgentixCare for Healthcare Operations
Taiwanese Health Technology Groups Test US Market in Dallas
NAMI joins Common Sense Media youth AI safety standards program
Cognizant Launches AI Nexus to Track AI Costs and Quality
Daily AI Brief: the AI news that matters, in your inbox.